Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-22

Clinical Trial Update: Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating antenatal phenobarbital to prevent neonatal intracranial hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenobarbital (phenobarbital)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 3 | Status: COMPLETED